All News

Cancer is a nasty side dish, but don't let it spoil the main course: your life.

A recent survey of physicians revealed that 17 percent of doctors with personal experience with cancer were more likely than those without to act against established guidelines to recommend that low-risk women receive ovarian cancer screening.

Positive results, clinical utility, curtailed curiosity – has the desire for good news slowed the path to a cure?

As a parent facing cancer, we just want to know that our children will emerge on the other side of our diagnosis and be alright.

The FDA has approved Imbruvica (ibrutinib) for use in combination with Rituxan (rituximab) as a treatment option across all lines of therapy for patients with Waldenström macroglobulinemia.

Broad-based genomic sequencing, while useful in identifying tumor mutations in patients with non-small cell lung cancer (NSCLC), may not improve survival outcomes when compared to routine genomic testing.

Senator and former presidential candidate John McCain died of glioblastoma on Aug. 25. He was 81 years old.

If opting for the flat and fabulous look, it's important to learn to make friends with your belly because you're going to see it more often.

The senator's family announced that he will no longer be undergoing treatment for glioblastoma.

"One of the big challenges in lymphoma is that many immune cells are present right in the tumor, but somehow those immune cells are not actually killing the tumor cells," explained Stephen M. Ansell, M.D., Ph.D.

An article Honoring the Hero for Colorado's Light the Night Walk.

According to a recent study conducted at the University of Alabama at Birmingham Schools of Public Health and Medicine, disparities among patients who receive instructions for this follow-up care still exist.

CURE spoke with Matthew Mossanen, M.D., from the Division of Urology at Brigham and Women’s Hospital, about what Bacillus Calmette-Guérin (BCG) is and what patients should know about this treatment option.

A guy with breast cancer ponders some of cancer's puzzling peculiarities.

The FDA has granted a priority review to a supplemental biologics license application (sBLA) for Empliciti (elotuzumab) for use in combination with Pomalyst (pomalidomide) and low-dose dexamethasone (EPd) for the treatment of patients with relapsed/refractory multiple myeloma following two or more prior therapies, including Revlimid (lenalidomide) and a proteasome inhibitor (PI).

Some days, the wind is at our back, and others, it is fighting against us. Life after cancer is all about finding pace.

There are many fears associated with cancer, but not all of them have names.

Moving on and focusing on your own future after cancer is an important step in the healing process.

In recent decades, researchers have gained a much better understanding of how gynecologic cancers develop, especially for women who carry genetic mutations.

Wistfully, I recall the days I could work all day, come home and do things around the house and then go out for dinner! Those days are long gone. I am off the chemo this week, but next week I will feel even more fatigue when I go back on.

As a person with metastatic cancer, I've surrendered a lot of my autonomy. Pay attention when I say I don't need your help.

I realized after facing my own cancer battle two years ago, I was free to fly to the other side of the "I have cancer" conversation.

A common goal for palliative care is pain management, where opioids like morphine are often on the frontline. Then, practitioners may build on medications from there, adding agents such as gabapentin and tricyclic antidepressants. But if those don’t work, Christopher J. Pietras, M.D. said that ketamine may be an option.

Talazoparib reduced the risk for disease progression or death by 46 percent and improved quality of life compared with chemotherapy in a subgroup of women with breast cancer, according to the phase 3 EMBRACA trial results.

The Food and Drug Administration (FDA) has granted a full approval to frontline Keytruda (pembrolizumab) for use in combination with standard chemotherapy for patients with metastatic nonsquamous non–small cell lung cancer (NSCLC), based on findings from the phase 3 KEYNOTE-189 trial.

CAR-T cell therapy has been showing promising in treating children with acute lymphoblastic leukemia, but it can come with significant toxicities.

While the treatment landscape of mantle cell lymphoma (MCL) has continued to evolve in recent years, researchers and clinicians alike are still at a loss for curative strategies. But immunotherapy may help.

I certainly was not used to people talking about my body all the time. "Are they taking your breast off?" several women asked. What? Who asks that question? If you do, you shouldn't.